Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acorda Therapeutics (NQ: ACOR )

0.5551 -0.0241 (-4.16%)
Streaming Delayed Price Updated: 11:17 AM EDT, May 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 153,873
Open 0.6300
Bid (Size) 0.5550 (30)
Ask (Size) 0.5551 (47)
Prev. Close 0.5792
Today's Range 0.5551 - 0.6490
52wk Range 0.5320 - 6.360
Shares Outstanding 13,285,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to tackle the biggest pre-market stock movers for this morning as we get ready for trading hours to start on Thursday! 
Via InvestorPlace

Performance

YTD
-77.80%
-77.80%
1 Month
-63.24%
-63.24%
3 Month
-74.30%
-74.30%
6 Month
-84.19%
-84.19%
1 Year
-87.18%
-87.18%

More News

Read More
24 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Via Benzinga
Acorda Therapeutics Reports First Quarter 2022 Financial Results
From Acorda Therapeutics, Inc.
Via Business Wire
Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA® in Latin America
From Acorda Therapeutics, Inc.
Via Business Wire
92 Biggest Movers From Friday
Via Benzinga
Acorda First Quarter 2022 Update: Webcast/Conference Call Scheduled for May 11, 2022
From Acorda Therapeutics, Inc.
Via Business Wire
78 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute
Via Benzinga
Earnings Scheduled For March 9, 2022
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
Acorda Fourth Quarter/Year End 2021 Update: Webcast/Conference Call Scheduled for March 9, 2022
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
From Acorda Therapeutics, Inc.
Via Business Wire
John Varian Joins Acorda Therapeutics Board of Directors
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Acorda Inks Distribution Pact In Germany For Inhaled Levodopa Powder; Q3 Earnings Beat Expectations
Via Benzinga
Topics Earnings
Exposures Financial
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
From Acorda Therapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.